US · Basic Materials · Specialty Chemicals
EPS came in at -0.77 against a street estimate of -0.24 — a miss of 220.8%.
Analysts rate Westlake Chemical Corporation a buy (6 buy, 8 hold, 0 sell out of 14) with an average price target of $96.00.
| Fund | Stake |
|---|---|
| Orbis Allan Gray Ltd | 4.13% |
| Capital World Investors | 3.29% |
| BlackRock Inc | 2.40% |
| T. Rowe Price Associates, Inc. | 1.88% |
| Brandes Investment Partners & Co | 1.44% |
| Wellington Management Company LLP | 1.40% |
| Vanguard Portfolio Management, LLC | 1.38% |
| Dimensional Fund Advisors, Inc. | 1.14% |
| Document | Date |
|---|---|
| Company announcement · Q3 2026 | 2026-07-29 |
| Reg FD disclosure · Q2 2026 | 2026-06-15 |
| Shareholder vote results · Q2 2026 | 2026-05-18 |
| Quarterly report · Q1 2026 | 2026-05-06 |
| Results announced · Q2 2026 | 2026-05-05 |
| Proxy statement · Q2 2026 | 2026-04-02 |
| Annual report FY2025 | 2026-02-26 |
| Quarterly report · Q3 2025 | 2025-10-31 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Westlake Chemical Corporation — free to start.
Google PlayApp StoreData updated 2026-08-05.